| Year |
Citation |
Score |
| 2011 |
Jatoi I, Anderson WF, Jeong JH, Redmond CK. Breast cancer adjuvant therapy: time to consider its time-dependent effects. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2301-4. PMID 21555693 DOI: 10.1200/Jco.2010.32.3550 |
0.469 |
|
| 2008 |
Fisher B, Redmond CK, Fisher ER. Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2068-71. PMID 18445835 DOI: 10.1200/Jco.2007.14.1804 |
0.484 |
|
| 1999 |
Arena VC, Costantino JP, Sussman NB, Redmond CK. Issues and findings in the evaluation of occupational risk among women high nickel alloys workers American Journal of Industrial Medicine. 36: 114-121. PMID 10361595 DOI: 10.1002/(Sici)1097-0274(199907)36:1<114::Aid-Ajim16>3.0.Co;2-V |
0.362 |
|
| 1998 |
Arena VC, Sussman NB, Redmond CK, Costantino JP, Trauth JM. Using alternative comparison populations to assess occupation-related mortality risk. Results for the high nickel alloys workers cohort Journal of Occupational and Environmental Medicine. 40: 907-916. PMID 9800177 DOI: 10.1097/00043764-199810000-00012 |
0.313 |
|
| 1998 |
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study Journal of the National Cancer Institute. 90: 1371-1388. PMID 9747868 DOI: 10.1093/Jnci/90.18.1371 |
0.49 |
|
| 1998 |
Gorin MB, Day R, Costantino JP, Fisher B, Redmond CK, Wickerham L, Gomolin JE, Margolese RG, Mathen MK, Bowman DM, Kaufman DI, Dimitrov NV, Singerman LJ, Bornstein R, Wolmark N, et al. Long-term tamoxifen citrate use and potential ocular toxicity. American Journal of Ophthalmology. 125: 493-501. PMID 9559735 DOI: 10.1016/S0002-9394(99)80190-1 |
0.321 |
|
| 1998 |
Costantino J, Day R, Cronin W, Wickerham D, Fisher B, Redmond C, Kavanah M, Wolmark N. Demographic characteristics and quality of life factors among the participants of the breast cancer prevention trial Controlled Clinical Trials. 19. DOI: 10.1016/S0197-2456(98)80154-2 |
0.406 |
|
| 1997 |
Anderson SJ, Costantino JP, Redmond CK, Freedman L. 107 Global monitoring of prevention trials: the breast cancer prevention trial (bcpt) experience Controlled Clinical Trials. 18. DOI: 10.1016/S0197-2456(97)91092-8 |
0.417 |
|
| 1997 |
Redmond CK, Mauldin PD, Portwood GL, Hawes RH, Cotton PB. 93 Issues in the design of a multicenter trial comparing radiation therapy to expandable esophageal stents for patients with advanced unresectable esophageal cancer Controlled Clinical Trials. 18. DOI: 10.1016/S0197-2456(97)91078-3 |
0.334 |
|
| 1996 |
Redmond CK, Costantino JP. Design and current status of the NSABP breast cancer prevention trial Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 140: 309-317. PMID 8787073 DOI: 10.1007/978-3-642-79278-6_35 |
0.388 |
|
| 1995 |
Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer. 75: 1310-9. PMID 7882281 DOI: 10.1002/1097-0142(19950315)75:6<1310::Aid-Cncr2820750613>3.0.Co;2-G |
0.387 |
|
| 1995 |
Ganz PA, Day R, Ware JE, Redmond C, Fisher B. Base-Line Quality-of-Life Assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Journal of the National Cancer Institute. 87: 1372-1382. PMID 7658498 DOI: 10.1093/Jnci/87.18.1372 |
0.462 |
|
| 1995 |
Costantino JP, Redmond CK, Bearden A. Occupationally related cancer risk among coke oven workers: 30 years of follow-up Journal of Occupational and Environmental Medicine. 37: 597-604. PMID 7640988 DOI: 10.1097/00043764-199505000-00009 |
0.358 |
|
| 1995 |
Mayberry RM, Coates RJ, Hill HA, Click LA, Chen VW, Austin DF, Redmond CK, Fenoglio-preiser CM, Hunter CP, Haynes MA, Muss HB, Wesley MN, Greenberg RS, Edwards BK. Determinants of black/white differences in colon cancer survival Journal of the National Cancer Institute. 87: 1686-1693. PMID 7473817 DOI: 10.1093/Jnci/87.22.1686 |
0.389 |
|
| 1994 |
Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, Hunter CP, Herman AA, Kurman RJ, Blacklow R, Shapiro S, et al. Racial Differences in Survival From Breast Cancer: Results of the National Cancer Institute Black/White Cancer Survival Study Jama. 272: 947-954. DOI: 10.1001/Jama.1994.03520120057031 |
0.453 |
|
| 1993 |
Fisher ER, Anderson S, Redmond C, Fisher B. Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants Cancer. 71: 2507-2514. PMID 8453574 DOI: 10.1002/1097-0142(19930415)71:8<2507::Aid-Cncr2820710813>3.0.Co;2-0 |
0.374 |
|
| 1993 |
Fisher ER, Costantino J, Fisher B, Redmond C. Pathologic findings from the national surgical adjuvant breast project (protocol 4): Discriminants for 15‐year survival Cancer. 71: 2141-2150. PMID 8443763 DOI: 10.1002/1097-0142(19930315)71:6+<2141::Aid-Cncr2820711603>3.0.Co;2-F |
0.446 |
|
| 1993 |
Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 11: 1879-87. PMID 8410113 DOI: 10.1200/Jco.1993.11.10.1879 |
0.4 |
|
| 1993 |
Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, Blacklow RS. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. Journal of the National Cancer Institute. 85: 1129-37. PMID 8320742 DOI: 10.1093/Jnci/85.14.1129 |
0.442 |
|
| 1993 |
Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L, Mamounas E, Poller W, Kavanah M. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer New England Journal of Medicine. 328: 1581-1586. PMID 8292119 DOI: 10.1056/Nejm199306033282201 |
0.479 |
|
| 1993 |
Redmond CK, Mazumdar S. Design, Analysis and Interpretation of Long-Term Mortality Studies of Coke Oven Workers International Statistical Review / Revue Internationale De Statistique. 61: 207. DOI: 10.2307/1403624 |
0.352 |
|
| 1991 |
Mazumdar S, Redmond CK, Costantino JP, Patwardhan RN, Zhou SYJ. Recent developments in the multistage modeling of cohort data for carcinogenic risk assessment Environmental Health Perspectives. 90: 271-277. PMID 2050072 DOI: 10.1289/Ehp.90-1519516 |
0.34 |
|
| 1991 |
Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R. DNA flow cytometric analysis of primary operable breast cancer: Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04 Cancer. 68: 1465-1475. PMID 1893345 DOI: 10.1002/1097-0142(19911001)68:7<1465::Aid-Cncr2820680702>3.0.Co;2-I |
0.386 |
|
| 1991 |
Fisher B, Redmond C. New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. Journal of the National Cancer Institute. 83: 1278-1281. PMID 1832192 DOI: 10.1093/Jnci/83.18.1278 |
0.48 |
|
| 1991 |
Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R. Significance of ipsilateral breast tumour recurrence after lumpectomy. The Lancet. 338: 327-331. PMID 1677695 DOI: 10.1016/0140-6736(91)90475-5 |
0.458 |
|
| 1991 |
Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B. Conservative management of intraductal carcinoma (DCIS) of the breast Journal of Surgical Oncology. 47: 139-147. PMID 1649353 DOI: 10.1002/Jso.2930470302 |
0.476 |
|
| 1990 |
Fisher ER, Redmond C, Fisher B, Bass G. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients. Cancer. 65: 2121-2128. PMID 2328478 DOI: 10.1002/1097-0142(19900501)65:9+<2121::Aid-Cncr2820651408>3.0.Co;2-M |
0.478 |
|
| 1990 |
Pollak M, Costantino J, Polychronakos C, Blauer SA, Guyda H, Redmond C, Fisher B, Margolese R. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients Journal of the National Cancer Institute. 82: 1693-1697. PMID 2231756 DOI: 10.1093/Jnci/82.21.1693 |
0.394 |
|
| 1990 |
Fisher B, Brown A, Wolmark N, Fisher ER, Redmond C, Wickerham DL, Margolese R, Dimitrov N, Pilch Y, Glass A. Evaluation of the worth of corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer. Eight-year results from the National Surgical Adjuvant Breast and Bowel Project B-10. Cancer. 66: 220-7. PMID 2196108 DOI: 10.1002/1097-0142(19900715)66:2<220::Aid-Cncr2820660205>3.0.Co;2-6 |
0.486 |
|
| 1990 |
Santen RJ, Manni A, Harvey H, Redmond C. Endocrine Treatment of Breast Cancer in Women Endocrine Reviews. 11: 221-265. PMID 2194783 DOI: 10.1210/Edrv-11-2-221 |
0.373 |
|
| 1989 |
Fisher B, Redmond C, Wickerham DL, Wolmark N, Bowman D, Couture J, Dimitrov NV, Margolese R, Legault-Poisson S, Robidoux A. Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Annals of Internal Medicine. 111: 703-12. PMID 2679288 DOI: 10.7326/0003-4819-111-9-703 |
0.468 |
|
| 1989 |
Redmond C, Fisher CK, Costantino B, Wickerham J, Wolmark DL, Fisher N. Treatment of Stage I Breast Cancer: The NSABP Experience Hormone Research in Paediatrics. 32: 175-180. PMID 2613203 DOI: 10.1159/000181340 |
0.472 |
|
| 1989 |
Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, Sldorovlch L. Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer Obstetrical & Gynecological Survey. 44: 618-619. DOI: 10.1097/00006254-198908000-00015 |
0.455 |
|
| 1988 |
Dong MH, Redmond CK, Mazumdar S, Costantino JP. A multistage approach to the cohort analysis of lifetime lung cancer risk among steelworkers exposed to coke oven emissions American Journal of Epidemiology. 128: 860-873. PMID 3421248 DOI: 10.1093/Oxfordjournals.Aje.A115039 |
0.335 |
|
| 1988 |
Fisher B, Redmond C, Fisher ER, Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. Journal of Clinical Oncology. 6: 1076-1087. PMID 2856862 DOI: 10.1200/Jco.1988.6.7.1076 |
0.443 |
|
| 1986 |
Fisher B, Fisher ER, Redmond C, Brown A. Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer. Breast Cancer Research and Treatment. 7: 147-160. PMID 3535933 DOI: 10.1007/Bf01806245 |
0.378 |
|
| 1986 |
Fisher B, Rockette H, Fisher ER, Wickerham DL, Redmond C, Brown A. Leukemia in Breast Cancer Patients Following Adjuvant Chemotherapy or Postoperative Radiation Journal of Clinical Oncology. 4: 614-614. DOI: 10.1200/Jco.1986.4.4.614 |
0.419 |
|
| 1985 |
Savitz DA, Redmond CK. Screening for geographic heterogeneity of disease rates: Application to cancer incidence in Allegheny County, Pennsylvania, 1969–1971 Journal of Chronic Diseases. 38: 145-156. PMID 3972957 DOI: 10.1016/0021-9681(85)90087-6 |
0.506 |
|
| 1985 |
Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation New England Journal of Medicine. 312: 674-681. PMID 3883168 DOI: 10.1056/Nejm198503143121102 |
0.457 |
|
| 1985 |
Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Wolmark N, Deutsch M, Montague E. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer New England Journal of Medicine. 312: 665-673. PMID 3883167 DOI: 10.1056/Nejm198503143121101 |
0.445 |
|
| 1983 |
Fisher ER, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation. Cancer. 51: 181-191. PMID 6821810 DOI: 10.1002/1097-0142(19830115)51:2<181::Aid-Cncr2820510202>3.0.Co;2-A |
0.474 |
|
| 1983 |
Fisher B, Redmond CK, Wickerham DL, Rockette HE, Brown A, Allegra J, Bowman D, Plotkin D, Wolter J. Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy Breast Cancer Research and Treatment. 3: 355-364. PMID 6365208 DOI: 10.1007/Bf01807588 |
0.436 |
|
| 1983 |
Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R, Poisson R, Shibata H, Volk H. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 52: 1551-1557. PMID 6352003 DOI: 10.1002/1097-0142(19831101)52:9<1551::Aid-Cncr2820520902>3.0.Co;2-3 |
0.391 |
|
| 1983 |
Wolmark N, Cruz I, Redmond CK, Fisher B, Fisher ER. Tumor size and regional lymph node metastasis in colorectal cancer a preliminary analysis from the NSABP clinical trials Cancer. 51: 1315-1322. PMID 6337699 DOI: 10.1002/1097-0142(19830401)51:7<1315::Aid-Cncr2820510723>3.0.Co;2-0 |
0.384 |
|
| 1982 |
Rockette HE, Redmond CK, Fisher B, Participating NSABP Investigators. Impact of randomized clinical trials on therapy of primary breast cancer: The NSABP overview Controlled Clinical Trials. 3: 209-225. PMID 7151439 DOI: 10.1016/0197-2456(82)90007-1 |
0.475 |
|
| 1981 |
Fisher ER, Osborne CK, McGuire WL, Redmond C, Knight WA, Fisher B, Bannayan G, Walder A, Gregory EJ, Jacobsen A, Queen DM, Bennett DE, Ford HC. Correlation of primary breast cancer histopathology and estrogen receptor content. Breast Cancer Research and Treatment. 1: 37-41. PMID 7348564 DOI: 10.1007/Bf01807890 |
0.376 |
|
| 1981 |
Osborne CK, Fisher E, Redmond C, Knight WA, Yochmowitz MG, McGuire WL. Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis. Advances in Experimental Medicine and Biology. 138: 377-85. PMID 7342719 DOI: 10.1007/978-1-4615-7192-6_23 |
0.485 |
|
| 1981 |
Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher ER. Findings from NSABP protocol no. b‐04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial‐central breast cancers Cancer. 48: 1863-1872. PMID 7284980 DOI: 10.1002/1097-0142(19811015)48:8<1863::Aid-Cncr2820480825>3.0.Co;2-U |
0.419 |
|
| 1981 |
Santen RJ, Veldhuis JD, Harvey H, Lipton A, Hubay CA, Pearson OH, Fisher B, Redmond C, Brown A, Wolmark N. Chemotherapy and Tamoxifen for Breast Cancer The New England Journal of Medicine. 305: 1014-1015. PMID 7278914 DOI: 10.1056/Nejm198110223051713 |
0.455 |
|
| 1981 |
Fisher B, Redmond C, Wolmark N, Wieand HS. Disease‐free survival at intervals during and following completion of adjuvant chemotherapy: The NSABP experience from three breast cancer protocols Cancer. 48: 1273-1280. PMID 7023651 DOI: 10.1002/1097-0142(19810915)48:6<1273::Aid-Cncr2820480602>3.0.Co;2-3 |
0.411 |
|
| 1981 |
Redmond C, Wieand HS, Fisher B. Statistical approaches for relating end results to amount of drug received in breast cancer therapy trials Controlled Clinical Trials. 2: 75-76. DOI: 10.1016/0197-2456(81)90088-X |
0.426 |
|
| 1980 |
Fisher ER, Redmond C, Fisher B. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five‐year treatment failure Cancer. 46: 908-918. PMID 7397667 DOI: 10.1002/1097-0142(19800815)46:4+<908::Aid-Cncr2820461310>3.0.Co;2-5 |
0.465 |
|
| 1980 |
Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. American Journal of Clinical Pathology. 73: 313-22. PMID 7361710 DOI: 10.1093/Ajcp/73.3.313 |
0.458 |
|
| 1980 |
Vernick LJ, Kuller LH, Lohsoonthorn P, Rycheck RR, Redmond CK. Relationship between cholecystectomy and ascending colon cancer. Cancer. 45: 392-5. PMID 7351021 DOI: 10.1002/1097-0142(19800115)45:2<392::Aid-Cncr2820450234>3.0.Co;2-9 |
0.356 |
|
| 1980 |
Fisher ER, Redmond CK, Liu H, Rockette H, Fisher B. Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer. 45: 349-53. PMID 7351016 DOI: 10.1002/1097-0142(19800115)45:2<349::Aid-Cncr2820450226>3.0.Co;2-P |
0.393 |
|
| 1980 |
Fisher B, Redmond C, Fisher ER. The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings Cancer. 46: 1009-1025. PMID 6994873 DOI: 10.1002/1097-0142(19800815)46:4+<1009::Aid-Cncr2820461326>3.0.Co;2-H |
0.473 |
|
| 1980 |
Fisher B, Montague E, Redmond C, Deutsch M, Brown GR, Zauber A, Hanson WF, Wong A. Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome Cancer. 46: 1-13. PMID 6992972 DOI: 10.1002/1097-0142(19800701)46:1<1::Aid-Cncr2820460102>3.0.Co;2-3 |
0.374 |
|
| 1980 |
Oleson CE, Bauer M, Redmond CK. Data monitoring at the national surgical adjuvant project for breast and bowel cancers (NSABP) Controlled Clinical Trials. 1: 173. DOI: 10.1016/0197-2456(80)90042-2 |
0.437 |
|
| 1979 |
Fisher B, Sherman B, Rockette H, Redmond C, Margolese R, Fisher ER. 1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers. Cancer. 44: 847-57. PMID 383274 DOI: 10.1002/1097-0142(197909)44:3<847::Aid-Cncr2820440309>3.0.Co;2-3 |
0.411 |
|
| 1979 |
Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 42: 2025-31. PMID 213191 DOI: 10.1002/1097-0142(197810)42:4<2025::Aid-Cncr2820420452>3.0.Co;2-J |
0.451 |
|
| 1978 |
Fisher ER, Palekar A, Kim WS, Redmond C. The histopathology of mammographic patterns. American Journal of Clinical Pathology. 69: 421-426. PMID 645642 DOI: 10.1093/Ajcp/69.4.421 |
0.416 |
|
| 1978 |
Fisher ER, Palekar A, Rockette H, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer. 42: 2032-8. PMID 361220 DOI: 10.1002/1097-0142(197810)42:4<2032::Aid-Cncr2820420453>3.0.Co;2-O |
0.38 |
|
| 1978 |
Fisher B, Redmond C, Fisher ER. Clinical trials and the surgical treatment of breast cancer. Surgical Clinics of North America. 58: 723-736. PMID 356295 DOI: 10.1016/S0039-6109(16)41584-7 |
0.465 |
|
| 1978 |
Fisher ER, Palekar AS, Gregorio RM, Redmond C, Fisher B. Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis. Human Pathology. 9: 523-30. PMID 213374 DOI: 10.1016/S0046-8177(78)80133-6 |
0.416 |
|
| 1977 |
Fisher ER, Gregorio R, Kim WS, Redmond C. Lipid in invasive cancer of the breast. American Journal of Clinical Pathology. 68: 558-561. PMID 920651 DOI: 10.1093/Ajcp/68.5.558 |
0.426 |
|
| 1977 |
Fisher ER, Redmond C, Fisher B. A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer. 40: 3160-3167. PMID 589573 DOI: 10.1002/1097-0142(197712)40:6<3160::Aid-Cncr2820400661>3.0.Co;2-P |
0.414 |
|
| 1977 |
Lerer TJ, Redmond CK, Campbell J. Factors Related to the Incidence of Stomach Cancer in the Pittsburgh Standard Metropolitan Statistical Area Journal of the National Cancer Institute. 59: 1065-1071. PMID 333121 DOI: 10.1093/Jnci/59.4.1065 |
0.396 |
|
| 1977 |
Fisher B, Montague E, Redmond C, Barton B, Borland D, Fisher ER, Deutsch M, Schwarz G, Margolese R, Donegan W, Volk H, Konvolinka C, Gardner B, Cohn I, Lesnick G, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial Cancer. 39: 2827-2839. PMID 326381 DOI: 10.1002/1097-0142(197706)39:6<2827::Aid-Cncr2820390671>3.0.Co;2-I |
0.429 |
|
| 1977 |
Fisher B, Glass A, Redmond C, Fisher ER, Barton B, Such E, Carbone P, Economou S, Foster R, Frelick R, Lerner H, Levitt M, Margolese R, MacFarlane J, Plotkin D, et al. L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU) Cancer. 39: 2883-2903. PMID 194679 DOI: 10.1002/1097-0142(197706)39:6<2883::Aid-Cncr2820390676>3.0.Co;2-9 |
0.393 |
|
| 1976 |
Fisher ER, Gregorio RM, Redmond C, Kim WS, Fisher B. Pathologic findings from the national surgical adjuvant breast project. (Protocol no. 4). III. The significance of extranodal extension of axillary metastases. American Journal of Clinical Pathology. 65: 439-444. PMID 1266807 DOI: 10.1093/Ajcp/65.4.439 |
0.453 |
|
| 1976 |
Redmond CK, Strobino BR, Cypess RH. Cancer Experience Among Coke By‐Product Workers Annals of the New York Academy of Sciences. 271: 102-115. PMID 1069492 DOI: 10.1111/J.1749-6632.1976.Tb23099.X |
0.391 |
|
| 1976 |
Rockette HE, Redmond CK. Long-term mortality study of steelworkers: X. Mortality patterns among masons Journal of Occupational Medicine. 18: 541-545. PMID 956938 DOI: 10.1097/00043764-197608000-00007 |
0.33 |
|
| 1976 |
Fisher ER, Gregorio R, Redmond C, Dekker A, Fisher B. Pathologic Findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): II. The Significance of Regional Node Histology Other Than Sinus Histiocytosis in Invasive Mammary Cancer American Journal of Clinical Pathology. 65: 21-30. PMID 174420 DOI: 10.1093/Ajcp/65.1.21 |
0.456 |
|
| 1975 |
Mancuso TF, Redmond CK. Heart disease mortality among black migrants: a study of Ohio residents (1960-1967). American Heart Journal. 90: 380-8. PMID 1163430 DOI: 10.1016/0002-8703(75)90329-4 |
0.592 |
|
| 1975 |
Fisher ER, Gregorio R, Redmond C, Vellios F, Sommers SC, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer. Cancer. 35: 247-54. PMID 1109771 DOI: 10.1002/1097-0142(197501)35:1<247::Aid-Cncr2820350130>3.0.Co;2-S |
0.489 |
|
| 1975 |
Fisher B, Carbone P, Economou SG, Frelick R, Glass A, Lerner H, Redmond C, Zelen M, Band P, Katrych DL, Wolmark N, Fisher ER. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. The New England Journal of Medicine. 292: 117-122. PMID 1105174 DOI: 10.1056/Nejm197501162920301 |
0.422 |
|
| 1975 |
Mazumdar S, Redmond C, Sollecito W, Sussman N. An Epidemiological Study of Exposure to Coal Tar Pitch Volatiles Among Coke Oven Workers Journal of the Air Pollution Control Association. 25: 382-389. DOI: 10.1080/00022470.1975.10470095 |
0.302 |
|
| Show low-probability matches. |